HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SRTCX1003

a SIRT1 activator; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - SRTCX1003: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - SRTCX1003: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - SRTCX1003: 1

Experts

1.	Considine, Thomas: 1 article (01/2012)
2.	Ellis, James L: 1 article (01/2012)
3.	Feldser, Heidi G: 1 article (01/2012)
4.	Lainez, Elden: 1 article (01/2012)
5.	Leung, Stewart: 1 article (01/2012)
6.	Loh, Christine: 1 article (01/2012)
7.	Miller, Christine: 1 article (01/2012)
8.	Pan, Heng: 1 article (01/2012)
9.	Riera, Thomas: 1 article (01/2012)
10.	Suri, Vipin: 1 article (01/2012)

Related Diseases

1.	Inflammation (Inflammations) 01/01/2012 - "In an acute mouse model of LPS-induced inflammation, the STAC SRTCX1003 decreased the production of the proinflammatory cytokines TNFα and IL-12. "

Related Drugs and Biologics

1.	Interleukin-12 (IL 12)
2.	Cytokines